Clinical Report: Mammography AI Spots Vascular Signals
Overview
Artificial intelligence-based quantification of breast arterial calcification (BAC) on screening mammography can independently predict major adverse cardiovascular events (MACE) and mortality. The study involving 123,762 women demonstrated a clear dose-response relationship between BAC severity and cardiovascular outcomes.
Background
Breast cancer remains a leading cause of cancer-related mortality among women, making effective screening crucial. Recent advancements in artificial intelligence (AI) have the potential to enhance risk assessment in breast cancer screening by integrating cardiovascular risk factors. Understanding the relationship between BAC and cardiovascular outcomes can improve prognostic evaluations and patient management strategies.
16.1% of women in the Emory cohort and 20.6% in the Mayo cohort had detectable BAC.
Each 1 mm² increase in BAC area was associated with a 1% to 2% increase in cardiovascular risk.
Adding BAC to the PREVENT model improved discrimination, increasing the concordance index from 0.71 to 0.73 in the internal cohort.
In women under 50 years with moderate to severe BAC, event-free survival was lower compared to those with zero BAC.
The AI model demonstrated 0.91 sensitivity and 0.95 specificity for BAC detection.
Clinical Implications
Automated BAC quantification from routine mammography may serve as an effective cardiovascular risk assessment tool for women, providing insights without additional radiation exposure. Clinicians should consider integrating BAC findings into cardiovascular risk evaluations, especially in younger women.
Conclusion
The study underscores the potential of AI in enhancing cardiovascular risk assessment through mammography, highlighting the need for further integration of BAC into clinical practice and guidelines.